|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/12 | |
| A61K 39/395 |
| (11) | Number of the document | 3102599 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14845032.3 |
| Date of filing the European patent application | 2014-12-19 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/078709 |
| Date | 2014-12-19 |
| (87) | Number | WO 2015/117711 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 14154158 | 2014-02-06 | EP | |
| 14166200 | 2014-04-28 | EP |
| (72) |
NAGY, Eszter, AT
NAGY, Gįbor, HU
SZIJ RTO, Valeria, AT
GUACHALLA, Luis, AT
VASQUEZ, Maximiliano, US
|
| (73) |
ARSANIS Biosciences GmbH,
Helmut-Qualtinger-Gasse 2, 1030 Vienna,
AT
|
| (54) | E. COLI SPECIFIC ANTIBODY SEQUENCES |
| E. COLI SPECIFIC ANTIBODY SEQUENCES |